Abstract:Objective:To observe the changes of endothelial function in patients with congestive heart failure(CHF)caused by coronary heart disease(CHD)and to evaluate the effect of Losartan on it.Methods:Endothelial functions were assessed by endothelium-depended relaxation,Endothlin-1(ET-1)and von Willbrand factor(vWF).50 CHF patients,46 CHD patients and 52 healthy subjects were enrolled in this study.Their Endothelial functions were compared.Among them 25 CHF patients were treated with Losartan for 12 weeks,their endothelial functions were evaluated before and after the treatment.Results:Endothelium-dependent relaxation(△D%)of brachial artery was significantly decreased in CHF patients(5.42±4.17%)compared with healthy subjects(12.01±4.04%,P<0.01)and CHD(7.74±3.15%,P<0.01).Plasma ET-1 was markedly elevated in CHF patients(60.03±17.49pg/ml)compared with healthy controls(44.24±8.92pg/ml,P<0.01)and CHD(46.91±14.42 pg/ml,P<0.01).vWF was also elevated in CHF patients(171.24±46.95%)and CHD(168.69±46.92%)compared with healthy controls(132.0±37.47,P<0.01).After treatment with Losartan for 12 weeks,△D% increased significantly(P<0.01),Plasma ET-1 and vWF decreased significantly(P<0.05).Conclusions:Endothelial dysfunction is existed in CHF and CHF itself is an independent endothelium risk factor of endothelium dysfunction in patients with CHF.AT1 receptor antagonist(Losartan)can reverse vascular endothelium dysfunction in CHF patients.

Endothelial Dysfunction in Patients with Congestive Heart Failure Caused by Coronary Heart Disease and the Effect of Losartan on Endothelial Function.